Smallpox vaccine with integrated IL-15 demonstrates enhanced in vivo viral clearance in immunodeficient mice and confers long term protection against a lethal monkeypox challenge in cynomolgus monkeys
- 8 October 2010
- journal article
- Published by Elsevier BV in Vaccine
- Vol. 28 (43), 7081-7091
- https://doi.org/10.1016/j.vaccine.2010.08.008
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Epidermal injury and infection during poxvirus immunization is crucial for the generation of highly protective T cell–mediated immunityNature Medicine, 2010
- Microneedle-Based VaccinesPublished by Springer Science and Business Media LLC ,2009
- New insights into the regulation of T cells by γc family cytokinesNature Reviews Immunology, 2009
- Immunity from Smallpox Vaccine Persists for Decades: A Longitudinal StudyAmerican Journal Of Medicine, 2008
- Vaccinia virus strain NYVAC induces substantially lower and qualitatively different human antibody responses compared with strains Lister and DryvaxJournal of General Virology, 2008
- Rapid protection in a monkeypox model by a single injection of a replication-deficient vaccinia virusProceedings of the National Academy of Sciences of the United States of America, 2008
- DNA/MVA HIV-1/AIDS vaccine elicits long-lived vaccinia virus-specific immunity and confers protection against a lethal monkeypox challengeVirology, 2007
- Development of Smallpox Vaccine Candidates with Integrated Interleukin-15 That Demonstrate Superior Immunogenicity, Efficacy, and Safety in MiceJournal of Virology, 2007
- Immunization with vaccinia virus induces polyfunctional and phenotypically distinctive CD8+ T cell responsesThe Journal of Experimental Medicine, 2007
- The biology of interleukin-2 and interleukin-15: implications for cancer therapy and vaccine designNature Reviews Immunology, 2006